(Q36609851)

15 August 2017

1 reference

title

Review of dialysate calcium concentration in hemodialysis (English)

1 reference

15 August 2017

2

Patrick Cooney

1 reference

15 August 2017

Nigel Toussaint

1

1 reference

PubMed ID

17014507

15 August 2017

Peter G Kerr

series ordinal

3

1 reference

15 August 2017

1 October 2006

1 reference

Hemodialysis International

15 August 2017

1 reference

15 August 2017

10

1 reference

15 August 2017

4

1 reference

15 August 2017

326-337

1 reference

Individualizing the dialysate in the hemodialysis patient

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Low calcium dialysate and high-dose oral calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Effects of low dialysate calcium concentration on health-related quality of life in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

How do we have to use the calcium in the dialysate to optimize the management of secondary hyperparathyroidism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Symptomatic hypocalcemia due to the inadvertent use of a calcium-free hemodialysate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Optimal composition of the dialysate, with emphasis on its influence on blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Vascular calcification mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Pathophysiology of vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Calcium loading, calcium accumulation, and associated cardiovascular risks in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Nocturnal home haemodialysis: an update on a 5-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Calcium and phosphate balance with quotidian hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Is 2.5 mEq/L the optimal calcium concentration of dialysate in the use of sevelamer hydrochloride? A study of the dialysate calcium concentration recommended by K/DOQI guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

What's new in vitamin D for the nephrologist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

The impact of calcimimetic agents on the use of different classes of phosphate binders: results of recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

High dialysate calcium may improve the efficacy of calcimimetic treatment in hemodialysis patients with severe secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Calcium concentration in the dialysate and calcium supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

Effects of reduced dialysate calcium on calcium-phosphorus product and bone metabolism in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1542-4758.2006.00125.X

10.1111/J.1542-4758.2006.00125.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17014507